PSO

PSO Shares Out (Basic)

616.30MQuarterly

Period ending:

PSO FY Shares Out (Basic)
PSO FY Shares Out (Basic)1985-12-31: 444.76M1986-12-31: 456.11M1987-12-31: 477.44M1988-12-31: 521.46M1989-12-31: 571.83M1990-12-31: 608.14M1991-12-31: 616.76M1992-12-31: 618.92M1993-12-31: 621.30M1994-12-31: 625.84M1995-12-31: 629.02M1996-12-31: 636.28M1997-12-31: 650.23M1998-12-31: 675.24M1999-12-31: 699.82M2000-12-31: 729.30M2001-12-31: 795.62M2002-12-31: 796.30M2003-12-31: 798.17M2004-12-31: 795.60M2005-12-31: 800.01M2006-12-31: 798.40M2007-12-31: 796.80M2008-12-31: 797.00M2009-12-31: 799.30M2010-12-31: 801.20M2011-12-31: 800.20M2012-12-31: 804.30M2013-12-31: 807.80M2014-12-31: 810.90M2015-12-31: 813.30M2016-12-31: 814.80M2017-12-31: 813.40M2018-12-31: 778.10M2019-12-31: 777.00M2020-12-31: 755.40M2021-12-31: 754.10M2022-12-31: 738.10M2023-12-31: 717.27M2024-12-31: 684.00M2025-12-31: 651.30M814.80M0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

PSO shares out (basic) history

Weighted average basic shares outstanding. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Pearson, Plc Common Stock Shares Out (Basic) — Annual fiscal periods
Period endingShares Out (Basic)
651,300,000
684,000,000
717,267,552
738,100,000
754,100,000
755,400,000
777,000,000
778,100,000
813,400,000
814,800,000
813,300,000
810,900,000
807,800,000
804,300,000
800,200,000
801,200,000
799,300,000
797,000,000
796,800,000
798,400,000
800,006,555
795,600,000
798,165,138
796,300,000
795,620,574
729,297,344
699,821,365
675,241,822
650,233,529
636,278,072
629,016,696
625,839,844
621,301,484
618,918,845
616,763,124
608,140,240
571,833,360
521,457,564
477,435,472
456,105,180
444,759,280

Compare shares out (basic)

All PSO financial metrics · PSO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.